The percentage composition of the free and esterified fatty acids in the total lipid extracts of samples of serum taken from 47 patients with multiple sclerosis and from 38 control subjects has recently been described (Baker, Thompson, and Zilkha, 1964) . It was found that the percentage of linoleic acid was significantly reduced in the multiple sclerosis group taken as a whole. Furthermore, when the patients were graded according to the activity of the disease, the percentage of linoleic acid was found to fall progressively with increasing evidence of recent deterioration in the patients' condition; the mean percentage of linoleic acid in the patients placed in the grade showing the greatest deterioration was 186 Y, compared with 256 Y% in the control group.
Since it is known that the cholesterol ester fraction of the serum lipids contains a much higher proportion of linoleic acid than either the phospholipid or triglyceride fractions (Lewis, 1958; Luddy, Barford, Riemenschneider, and Evans, 1958; Tuna, Reckers, and Frantz, 1958; Wright, Pitt, and Morton, 1959; Riley and Nunn, 1960; Lawrie, McAlpine, Pirrie, and Rifkind, 1961) , it was decided to compare the levels of cholesterol linoleate in serum from normal subjects and from patients with multiple sclerosis.
SUBJECTS
The subjects of the present study consisted of 23 controls and 35 patients with multiple sclerosis.
The controls included eight healthy subjects, five women and three men, aged 24 to 52 years (mean 33 years), and 15 'neurological controls', 10 women and five men, i.e., in-patients in the National Hospital, Queen Square, the Cheshire Foundation Home for the Chronic Sick (Copthorne, Sussex), and Guy's Hospital, suffering from neurological disorders other than multiple sclerosis (Table I) , whose ages ranged from 13 to 54 years (mean 36 years).
The 35 patients with multiple sclerosis, aged 19 Blood (20 ml.) was drawn from each subject from the antecubital vein after an overnight fast; in the case of the women it was drawn between approximately the twelfth and twentieth days of the menstrual cycle. For the most part the specimens were taken in pairs, one from a control and one from a patient with multiple sclerosis. The subsequent analyses were carried through 'blind', the analyst being unaware of the identity of the specimens. Sera from 35 patients with multiple sclerosis and 23 controls were thus examined.
The neurological controls were chosen, as far as possible, so as to be of the same sex and of a similar age and weight, and showing a degree of physical handicap comparable to that of the multiple sclerosis patients. All patients in the study were taking a normal diet. Eight of the control subjects and 14 of the patients with multiple sclerosis had been included in our earlier study (Baker et al., 1964) .
ANALYTICAL METHODS
TOTAL CHOLESTEROL ESTERS In all cases a lipid extract of the serum was prepared by the method of Webster (1962) .
The total cholesterol esters were estimated either after precipitation of the free cholesterol with digitonin, as described by Webster (1962) , or after elution with diethyl 212 ether from thin-layer silicic acid-CaSO4 plates developed with 20 % peroxide-free diisopropyl ether in hexane. The colour development was carried out as described by Webster except that smaller volumes of reagents were used and that the H2SO4 was added immediately after taking the tubes from the 80°C. bath, after which the tubes were mixed quickly, well shaken, and allowed to cool out of direct sunlight. Standards of either recrystallized cholesterol stearate or cholesterol oleate, purified on a silicic acid column, were taken, together with blanks, through the whole procedure. All estimates were done in duplicate.
Cholesterol linoleate was separated from the other fatty acid esters of cholesterol by a modification of the method of Zollner, Wolfram, and Amin (1962) . To achieve satisfactory separation of the cholesterol esters by this technique it was found necessary to use very thin layers (12) (13) (14) (15) (16) After staining with iodine, the zones of silicic acid containing the separated groups of esters were scraped from the plates to give three fractions containing the following types of esters: fraction 1, saturated and monoenoic esters; fraction 2, di-enoic esters; fraction 3, triand poly-enoic esters.
The esters were then eluted from each of these three fractions with diethyl ether, and the colour development carried out by the addition of 0 4 ml. FeCl3 reagent and 0 3 ml. conc. H2SO4, the optical density being read in 1 cm. micro-cells. From the readings obtained for these fractions the amount of cholesterol linoleate, i.e., fraction 2, was calculated as a percentage of the sum of all three fractions, and from our estimate of the total cholesterol esters, the absolute level of cholesterol linoleate was calculated in ,umoles/ml. serum (method A).
To avoid staining with iodine which, if prolonged, may lead to changes in the percentages of fractions 1, 2, and 3 recovered from the plate, thin-layer plates impregnated with AgNO3, as described by Morris (1963) , were used in the later stages of the work. The plates were prepared by spreading on each plate (20 x 5 cm.) 1 g. silicic acid (Merck) incorporating 11 % CaSO4, shaken up in 3 2 ml.
0-1 N AgNO3 containing 2-5 mg. % 2',7'-dichlorofluorescein. After applying the cholesterol esters (0 3-0 6 ,xmole) the plates were developed in 50% diisopropyl ether in hexane, and the three fractions 1, 2 and 3, eluted, and estimated as described above, except that 5-fold volumes of reagents were used. Recoveries of total serum cholesterol esters from these plates averaged 940% (22 experiments).
The use of AgNO3-impregnated plates necessitated the preliminary separation of cholesterol esters from free cholesterol; this was achieved either by precipitation with digitonin (method B), or more usually by separation on silicic acid-CaSO4 thin-layer plates, using 20% peroxidefree diisopropyl ether in hexane as the running solvent (method C), after quantitative application of the whole of the lipid extracts. Recoveries from these plates of cholesterol oleate averaged 98 % (five experiments). All estimations by methods A, B, or C were done in duplicate.
RESULTS
Since our estimations of serum cholesterol linoleate levels are derived from measurements of the level of total cholesterol esters, together with determination of the percentage of cholesterol linoleate in the total ester fractions, experiments have been carried out to satisfy ourselves as to (a) the validity of our estimates of total cholesterol esters, and (b) the accuracy of our determinations of the linoleate percentage. Table II gives a comparison of the estimates of total cholesterol esters in a series of specimens carried out by the classical method of Sperry and Webb (1950) and by the Webster technique carried out either after precipitation of free cholesterol with digitonin or after separation on thin-layer plates. It will be seen that the results obtained with the three methods agree well. The analyses reported in Table III show that the three methods which we have used for the estimation of the percentage of cholesterol linoleate in the total cholesterol esters give essentially the same results. The di-enoic esters of cholesterol present in our fraction 2 (see under Methods) were shown by gas chromatographic examination of the fatty acid moieties to consist of at least 97 % cholesterol linoleate.
The mean levels of total cholesterol esters and of cholesterol linoleate in the sera of the control subjects and patients with multiple sclerosis are shown in Table IV . and esterified linoleic acid in the serum lipids (Baker et al., 1964) , M.C., J.P.)
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It will be noticed that the mean value both of total cholesterol esters and of cholesterol linoleate is higher in the grade A patients than in the controls. As, however, these differences are not statistically significant it is not proposed to comment further on them.
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SUMMARY
Estimations have been made of the levels of total cholesterol esters and of cholesterol linoleate in serum from 35 patients with multiple sclerosis and 23 control subjects.
When the patients with multiple sclerosis were graded according to the activity of the disease it was found that the level of cholesterol linoleate is reduced in patients showing evidence of recent deterioration, the mean level in the eight patients showing the greatest deterioration being 1 52 umoles/ml. compared with a mean of 2-17 ,umoles/ml. in the control group.
The level of total cholesterol esters also showed a significant though less striking fall in the group showing the greatest deterioration.
